Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Targeting organic anion transporter 3 with probenecid as a novel anti-influenza a virus strategy.

Perwitasari O, Yan X, Johnson S, White C, Brooks P, Tompkins SM, Tripp RA.

Antimicrob Agents Chemother. 2013 Jan;57(1):475-83. doi: 10.1128/AAC.01532-12. Epub 2012 Nov 5.

2.

Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.

Yu J, Wang D, Jin J, Xu J, Li M, Wang H, Dou J, Zhou C.

Antiviral Res. 2016 Mar;127:68-78. doi: 10.1016/j.antiviral.2016.01.011. Epub 2016 Jan 21.

PMID:
26802558
3.

Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses.

Kumar N, Sharma NR, Ly H, Parslow TG, Liang Y.

Antimicrob Agents Chemother. 2011 Dec;55(12):5553-9. doi: 10.1128/AAC.00725-11. Epub 2011 Sep 19.

4.

Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.

Gao L, Han J, Si J, Wang J, Wang H, Sun Y, Bi Y, Liu J, Cao L.

Antiviral Res. 2017 Jul;143:106-112. doi: 10.1016/j.antiviral.2017.02.010. Epub 2017 Feb 21.

PMID:
28232246
5.

Germacrone inhibits early stages of influenza virus infection.

Liao Q, Qian Z, Liu R, An L, Chen X.

Antiviral Res. 2013 Dec;100(3):578-88. doi: 10.1016/j.antiviral.2013.09.021. Epub 2013 Oct 3.

PMID:
24095670
6.

Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.

Haasbach E, Pauli EK, Spranger R, Mitzner D, Schubert U, Kircheis R, Planz O.

Antiviral Res. 2011 Sep;91(3):304-13. doi: 10.1016/j.antiviral.2011.07.006. Epub 2011 Jul 13.

PMID:
21777621
7.

The effect of rosuvastatin in a murine model of influenza A infection.

Radigan KA, Urich D, Misharin AV, Chiarella SE, Soberanes S, Gonzalez A, Perlman H, Wunderink RG, Budinger GR, Mutlu GM.

PLoS One. 2012;7(4):e35788. doi: 10.1371/journal.pone.0035788. Epub 2012 Apr 20.

8.

Identification of small molecules that interfere with H1N1 influenza A viral replication.

Bottini A, De SK, Baaten BJ, Wu B, Barile E, Soonthornvacharin S, Stebbins JL, Bradley LM, Chanda SK, Pellecchia M.

ChemMedChem. 2012 Dec;7(12):2227-35. doi: 10.1002/cmdc.201200453. Epub 2012 Nov 8.

9.

Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.

Wu W, Li R, Li X, He J, Jiang S, Liu S, Yang J.

Viruses. 2015 Dec 25;8(1). pii: E6. doi: 10.3390/v8010006.

10.

[Effect of Panavir on influenza A virus reproduction].

Prokudina EN, Galegov GA, Semenova NP, Grigor'eva TA, Kalinina TS, Litvin AA, Stovbun SV, Sergienko VI.

Antibiot Khimioter. 2006;51(6):7-10. Russian.

PMID:
17523415
11.

Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.

Ding Y, Dou J, Teng Z, Yu J, Wang T, Lu N, Wang H, Zhou C.

Arch Virol. 2014 Dec;159(12):3269-78. doi: 10.1007/s00705-014-2192-2. Epub 2014 Jul 31.

PMID:
25078390
12.

Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses.

Zhang J, Hu Y, Hau R, Musharrafieh R, Ma C, Zhou X, Chen Y, Wang J.

Eur J Pharm Sci. 2019 May 15;133:86-94. doi: 10.1016/j.ejps.2019.03.020. Epub 2019 Mar 28.

PMID:
30930289
13.

Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.

Lejal N, Tarus B, Bouguyon E, Chenavas S, Bertho N, Delmas B, Ruigrok RW, Di Primo C, Slama-Schwok A.

Antimicrob Agents Chemother. 2013 May;57(5):2231-42. doi: 10.1128/AAC.02335-12. Epub 2013 Mar 4.

14.

Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.

Kocik J, Kołodziej M, Joniec J, Kwiatek M, Bartoszcze M.

Acta Biochim Pol. 2014;61(3):509-13. Epub 2014 Sep 12.

15.

Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen.

Maddry JA, Chen X, Jonsson CB, Ananthan S, Hobrath J, Smee DF, Noah JW, Noah D, Xu X, Jia F, Maddox C, Sosa MI, White EL, Severson WE.

J Biomol Screen. 2011 Jan;16(1):73-81. doi: 10.1177/1087057110384613. Epub 2010 Nov 8.

PMID:
21059874
16.

In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.

Kumaki Y, Day CW, Smee DF, Morrey JD, Barnard DL.

Antiviral Res. 2011 Nov;92(2):329-40. doi: 10.1016/j.antiviral.2011.09.001. Epub 2011 Sep 8.

17.

The epidemiology and spread of drug resistant human influenza viruses.

Hurt AC.

Curr Opin Virol. 2014 Oct;8:22-9. doi: 10.1016/j.coviro.2014.04.009. Epub 2014 May 24. Review.

PMID:
24866471
18.

Identification of Novel and Efficacious Chemical Compounds that Disturb Influenza A Virus Entry in vitro.

Khalil H, El Malah T, El Maksoud AIA, El Halfawy I, El Rashedy AA, El Hefnawy M.

Front Cell Infect Microbiol. 2017 Jun 30;7:304. doi: 10.3389/fcimb.2017.00304. eCollection 2017.

19.

Anti-influenza A Virus Activity of Dendrobine and Its Mechanism of Action.

Li R, Liu T, Liu M, Chen F, Liu S, Yang J.

J Agric Food Chem. 2017 May 10;65(18):3665-3674. doi: 10.1021/acs.jafc.7b00276. Epub 2017 Apr 26.

PMID:
28417634
20.

Bakuchiol Is a Phenolic Isoprenoid with Novel Enantiomer-selective Anti-influenza A Virus Activity Involving Nrf2 Activation.

Shoji M, Arakaki Y, Esumi T, Kohnomi S, Yamamoto C, Suzuki Y, Takahashi E, Konishi S, Kido H, Kuzuhara T.

J Biol Chem. 2015 Nov 13;290(46):28001-17. doi: 10.1074/jbc.M115.669465. Epub 2015 Oct 7.

Supplemental Content

Support Center